Tsuda H - Search Results

1

Carcinogenesis and its modification by environmental endocrine disruptors: in vivo experimental and epidemiological findings.

Tsuda H, Naito A, Kim CK, Fukamachi K, Nomoto H, Moore MA. Tsuda H, et al. Jpn J Clin Oncol. 2003 Jun;33(6):259-70. doi: 10.1093/jjco/hyg052. Jpn J Clin Oncol. 2003. PMID: 12913079 Review.

2

Food and Play Preferences - Does Cancer Prevention Require Targeting the Child?

Moore MA, Tsuda H. Moore MA, et al. Among authors: tsuda h. Asian Pac J Cancer Prev. 2002;3(4):279-280. Asian Pac J Cancer Prev. 2002. PMID: 12716286 Free article.

3

Smoking-Related Research in the Asian-Pacific Countries.

Moore MA, Tsuda H. Moore MA, et al. Among authors: tsuda h. Asian Pac J Cancer Prev. 2002;3(4):291-304. Asian Pac J Cancer Prev. 2002. PMID: 12716287 Free article.

4

Cancer Screening: A Review with Particular Attention to Areas for Future International Research Efforts.

Tsuda H, Moore MA. Tsuda H, et al. Asian Pac J Cancer Prev. 2002;3(2):99-123. Asian Pac J Cancer Prev. 2002. PMID: 12718589 Free article.

5

Possible enhancing effects of atrazine and nonylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats.

Fukamachi K, Han BS, Kim CK, Takasuka N, Matsuoka Y, Matsuda E, Yamasaki T, Tsuda H. Fukamachi K, et al. Among authors: tsuda h. Cancer Sci. 2004 May;95(5):404-10. doi: 10.1111/j.1349-7006.2004.tb03223.x. Cancer Sci. 2004. PMID: 15132767 Free article.

6

Cancer prevention by natural compounds.

Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M, Takasuka N, Moore MA. Tsuda H, et al. Drug Metab Pharmacokinet. 2004 Aug;19(4):245-63. doi: 10.2133/dmpk.19.245. Drug Metab Pharmacokinet. 2004. PMID: 15499193 Free article. Review.

7

Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment.

Asamoto M, Ota T, Toriyama-Baba H, Hokaiwado N, Naito A, Tsuda H. Asamoto M, et al. Among authors: tsuda h. Jpn J Cancer Res. 2002 Jan;93(1):32-5. doi: 10.1111/j.1349-7006.2002.tb01197.x. Jpn J Cancer Res. 2002. PMID: 11802805 Free PMC article.

8

Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work.

Tsuda H, Fukushima S, Wanibuchi H, Morimura K, Nakae D, Imaida K, Tatematsu M, Hirose M, Wakabayashi K, Moore MA. Tsuda H, et al. Toxicol Pathol. 2003 Jan-Feb;31(1):80-6. doi: 10.1080/01926230390173879. Toxicol Pathol. 2003. PMID: 12597451 Review.

9

Cancer screening literature in the period 2000-2002: pointers to future research avenues.

Moore MA, Kunimoto T, Tsuda H. Moore MA, et al. Among authors: tsuda h. Asian Pac J Cancer Prev. 2003 Jan-Mar;4(1):57-60. Asian Pac J Cancer Prev. 2003. PMID: 12718702 Free article. Review.

10

Appropriate models and an understanding of carcinogenic mechanisms--requirements for hazard risk assessment.

Fukushima S, Moore MA, Tsuda H. Fukushima S, et al. Among authors: tsuda h. Asian Pac J Cancer Prev. 2003 Jan-Mar;4(1):75-8. Asian Pac J Cancer Prev. 2003. PMID: 12718706 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,863 results

Search Page